Ignite Creation Date:
2024-05-06 @ 12:41 PM
Last Modification Date:
2024-10-26 @ 1:02 PM
Study NCT ID:
NCT03823625
Status:
UNKNOWN
Last Update Posted:
2020-03-25
First Post:
2018-02-02
Brief Title:
An Open-label Randomized Parallel Non Comparative Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer SqLC
Sponsor:
Fondazione Ricerca Traslazionale
Organization:
Fondazione Ricerca Traslazionale
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-02-28
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-02
First Submit QC Date:
January 29 2019
Study First Post Date:
2019-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-24
Last Update Post Date:
2020-03-25
Last Update Post Date Type:
ACTUAL